TAT and infection: Since high levels of anti-Tat antibodies in HIV-infected individuals are associated with better CTL response, asymptomatic infection and slower disease progression [26,27,28,29], Tat has been considered as candidate for prophylactic and therapeutic HIV vaccine [30,31,32,33].